Summit Therapeutics Inc (NASDAQ:SMMT) concluded the trading at $20.46 on Wednesday, April 03 with a rise of 8.83% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $18.80 and 5Y monthly beta
Summit Therapeutics Inc (NASDAQ:SMMT) traded at $19.40 at last check on current trade day and made a downward move of -4.54% on its previous day’s price. Looking at the stock we see that its previous close was $20.32 and the beta (5Y monthly) reads -1.042
Summit Therapeutics Inc (NASDAQ:SMMT) shares, rose in value on Thursday, March 27, with the stock price up by 3.57% to the previous day’s close as strong demand from buyers drove the stock to $20.60. Actively observing the price movement in the last trading, the stock
The trading price of Summit Therapeutics Inc (NASDAQ:SMMT) closed higher on Friday, March 21, and closing at $19.75, 1.59% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $19.14 and $20.02. In examining the
Summit Therapeutics Inc (NASDAQ:SMMT) price on current trading day, rose 1.41% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $20.11. A look at the stock’s price movement, the close in the last trading session was $19.83, moving
Summit Therapeutics Inc (NASDAQ:SMMT) price closed lower on Monday, March 17, and dropping -3.17% below its previous close. A look at the daily price movement shows that the last close reads $20.79, with intraday deals fluctuated between $20.07 and $20.85. The company’s 5Y monthly beta
Summit Therapeutics Inc (NASDAQ:SMMT) concluded the trading at $19.19 on Thursday, March 13 with a fall of -3.62% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $19.91 and 5Y monthly beta
Summit Therapeutics Inc (NASDAQ:SMMT) traded at $17.99 at close of the session on Monday, March 10 and made an upward move of 1.18% on its previous day’s price. Summit Therapeutics Inc has a market cap of $13.27 billion and is expected to release its quarterly
Summit Therapeutics Inc (NASDAQ:SMMT) shares, rose in value on Thursday, March 06, with the stock price down by -2.86% to the previous day’s close as strong demand from buyers drove the stock to $18.99. Actively observing the price movement in the last trading, the stock
The trading price of Summit Therapeutics Inc (NASDAQ:SMMT) closed lower on Monday, March 03, and closing at $19.13, -7.54% lower than its previous close. In examining the 52-week price action we see that the stock hit a 52-week high of $33.89 and a 52-week low
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
